Latest News

Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • January 09, 2019 4:26 PM | Anonymous

    January 9, 2019, Endocrine Today  

    Swedish women with Addison's disease are more likely to develop ischemic heart disease than healthy adults or men with the condition, whereas both men and women with the disease were more likely to die of a coronary event vs. healthy controls, study data show.  

    Read more.

  • January 08, 2019 8:43 AM | Anonymous

    January 8, 2019, HealthDay News via Monthly Prescribing Reference 

    For women with provoked vulvodynia, gabapentin improves sexual function compared with placebo, although overall sexual function is still lower than for pain-free controls, according to a study published in the January issue of the American Journal of Obstetrics and Gynecology. 

    Read more.

  • January 07, 2019 8:50 AM | Anonymous

    January 7, 2019, MedPage Today 

    Long-term risk of stroke was lower in women who took aspirin after experiencing preeclampsia and other hypertensive disorders of pregnancy, a prospective U.S. cohort study found. 

    Read more.

  • January 04, 2019 9:58 AM | Anonymous

    January 4, 2019, Medpage Today

    Long-term risk of stroke was lower in women who took aspirin after experiencing preeclampsia and other hypertensive disorders of pregnancy, a prospective U.S. cohort study found. Women with preeclampsia and related disorders who did not use aspirin regularly showed 1.5-fold higher risk of stroke before age 60, compared to women not having a history of such conditions. 

    Read more.

  • December 27, 2018 9:21 AM | Anonymous

    December 27, 2018, ACOG  

    The Committee on Scientific Program and the American College of Obstetricians and Gynecologists are pleased to announce the call for session proposals for the 2020 ACOG Annual Clinical and Scientific Meeting in Seattle, WA, April 24 - 27, 2020.

    Since ACOG's last call for session proposals closed in January 2018, innovations and advances in obstetrics and gynecology continue to be made. This year's call provides you with a great opportunity to contribute to dynamic, cutting-edge conversations and help the coming year's meeting cover the field's best emerging ideas and most important issues.

    The Committee on Scientific Program will review these proposals for the 2020 Annual Meeting at their upcoming January meeting.

    If you are presenting a course at the 2019 Annual Meeting, you DO NOT need to resubmit a proposal. All course evaluations are reviewed after the Annual Meeting and the committee will determine whether the course will be repeated for the 2020 Annual Meeting. 

    Deadline: Monday, January 14, 2019

    Please contact us at with any questions.

    Session Types

    Clinical Seminars
    These 45-minute sessions are interactive lectures on topics of special interest with a course director leading the discussion.

    These 45-minute sessions are comprised of three 10-minute segments. Each speaker presents a concise lecture about a topic that is relevant to Ob-Gyn health care professionals. After each 10-minute lecture, a question/answer period follows to address questions from the audience.

    Hands-On Courses
    These three- and six-hour courses provide a didactic and interactive (hands-on) component so participants can further immerse themselves in learning. 

    Lunch Conversations
    Subjects of special interest will be the focus of these small group discussions. Each group is limited to nine attendees in addition to the discussion leader.

    Postgraduate Courses
    Clinically oriented three- and six-hour courses taught by leading experts in the field. Because learner participation is a valued part of each course, opportunities for interaction between participants and faculty are built into the program.

    Surgical Tutorials
    These tutorials will incorporate the use of slides, video, case-based formats, and interactive demonstrations.

    Trifecta Clinical Seminars
    Three clinical seminars in one room. Similar topic, three presentations with the opportunity to listen to one and watch all three.

  • December 27, 2018 8:58 AM | Anonymous

    December 27, 2018
    via Center for Healthy Women & Children, National Coalition for Sexual Health  

    Since 1970, a critical source of affordable high-quality family planning care for low-income women, men, and adolescents across the United States has been the network of providers that receive funds through the Federal Title X Family Planning Program. The program, administered by the Office of Population Affairs in the Department of Health and Human Services under the Office of the Assistant Secretary for Health, funds a network of approximately 4,000 service sites around the country. The Title X program is an important cornerstone in efforts to meet the needs of low-income Americans; Title X funds subsidize family planning services for women, men, and adolescents who may not have health insurance or who are not eligible for Medicaid. Millions of individuals (nearly 9 million) receive publicly funded family planning (FP) services each year, and 4.6 million of them obtain care from a health center that receives Title X funding.

    Read the report.

  • December 27, 2018 8:52 AM | Anonymous

    December 27, 2018, SELF 
    via Center for Healthy Women & Children, National Coalition for Sexual Health  

    Trying to understand health insurance can be like learning a foreign language that might cost you a boatload of money if anything gets lost in translation. But here’s one clear health insurance fact: The Affordable Care Act allows young adults to stay on a parent or guardian’s job- or marketplace-provided insurance until they are 26. This is excellent.

    Read more.

  • December 27, 2018 8:43 AM | Anonymous

    December 27, 2018, MedPage Today  

    Women's risk of breast cancer was highest about 5 years after childbirth, and lasted more than 20 years, compared with women who have never given birth, and breastfeeding did not appear to attenuate the risk, a large pooled analysis found. 

    Read more.

  • December 21, 2018 8:33 AM | Anonymous

    December 21, 2018, MedPage Today  

    Use of vaginal estrogen wasn't tied to increased cardiovascular or cancer risks, according to a new study.

    Looking at postmenopausal women who participated in the Nurses' Health Study, vaginal estrogen use in women with or without an intact uterus was not associated with any increased risks of several cancers or cardiovascular outcomes over an 18-year follow-up period, reported JoAnn E. Manson, MD, DrPH, of Brigham and Women's Hospital in Boston, and colleagues.

    Read more.

  • December 20, 2018 8:18 AM | Anonymous

    December 20, 2018, News Medical 

    Researchers at the Queen Mary University of London have developed a new cervical cancer test that proved to be 100 percent effective at detecting the cancer in a trial of 15,744 participants. The study demonstrated that the epigenetics-based test outperformed both the Pap smear and the human papilloma virus (HPV) test, as well as being more cost effective. 

    Read more.

Powered by Wild Apricot Membership Software